Evidence map›Paper›PMID 31691265›Full record

Observational studyJournal of the American Geriatrics Society2020

The Epidemiology of Depressive Symptoms in the Last Year of Life.

Elissa Kozlov, XinQi Dong, Amy S Kelley, Claire K Ankuda

Abstract readObservational Study
In one paragraph

Observational study in Journal of the American Geriatrics Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Hospice Referral in Advanced Cancer in New Jersey.Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Elissa KozlovInstitute for Health, Health Policy, and Aging Research, Rutgers University, New Brunswick, New Jersey.
XinQi DongInstitute for Health, Health Policy, and Aging Research, Rutgers University, New Brunswick, New Jersey.
Amy S KelleyDepartment of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Claire K AnkudaDepartment of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.ORCID 0000-0003-1371-8524

Funding

Unnecessary and Harmful Medication Use in Older Adults with DementiaP01AG066605 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MICHAEL A. STEINMAN · 2020 to 2026
$17.7M
Pilot CoreP30AG022845 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Manney Carrington Reid · 2003 to 2026
$15.2M
Social Distancing and Mental Health in Diverse Aging PopulationsR24AG063729 · NIA · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI HU, WILLIAM TZU-LUNG · 2019 to 2021
$4.0M
Research Education and Training CoreP30AG059304 · NIA · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI SIMON, MELISSA A. · 2018 to 2022
$3.1M
The Burden of Care for Adults with Dementia: Impact on Care Quality and Family OutcomesR01AG054540 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KELLEY, AMY STEVES · 2017 to 2021
$2.1M
Midcareer Investigator Award for Patient-Oriented Research in Dementia and Serious IllnessK24AG062785 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KELLEY, AMY STEVES · 2019 to 2022
$581k
NIA NIH HHS K24 AG062785NIA NIH HHS P01 AG066605NIA NIH HHS P30 AG022845NIA NIH HHS P30 AG059304NIA NIH HHS R01 AG054540NIA NIH HHS R24 AG063729
6 · The paper itself

Abstract

BACKGROUND/

objectiveDepression impacts quality of life at all life stages, but the epidemiology of depression in the last year of life is unknown. This study's objectives were to document the epidemiology of depressive symptoms in the year prior to death and to assess how the trajectory of depressive symptoms varies by sociodemographic and clinical factors.

designObservational, cross-sectional, cohort study using the Health and Retirement Study.

settingPopulation-based survey.

participantsA total of 3274 individuals who died within 12 months after assessment. MEASURES: Primary outcome: eight-item Center for Epidemiologic Studies Depression Scale (CESD-8). Covariates included sociodemographics, self-reported illnesses, and activity of daily living (ADL) limitations.

resultsAverage CESD-8 score increased over the last year of life, with 59.3% screening positive for depression in the last month before death. Depression symptoms increased gradually from 12 to 4 months before death (increase of 0.05 points/month; 95% confidence interval [CI] = 0.01-0.08 points/month) and then escalated from 4 to 1 months before death (increase of 0.29 points/month; 95% CI = 0.16-0.39 points/month). Women, younger adults, and nonwhite adults all demonstrated higher rates of depressive symptoms. Individuals with cancer reported escalating rates of depressive symptoms at the end of life, while individuals with lung disease and ADL impairment demonstrated persistently high rates throughout the year before death.

conclusionsThis study revealed high rates of depressive symptoms in the last year of life as well as differences in the burden of depressive symptoms. A public health approach must be taken to screen for and appropriately treat symptoms of depression across the lifespan. J Am Geriatr Soc 68:321-328, 2020.

Indexed as

Disease ProgressionQuality of LifeAgedAged, 80 and overCohort StudiesCross-Sectional StudiesDepressionFemaleHumansMaleSelf ReportTime Factorsdepressionend of lifemental health

Identifiers

PMID31691265
PMCPMC7899291

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.